Modern possibilities of antihypertensive and lipid-lowering therapy in the treatment of comorbid patients with a very high risk of cardiovascular events
| Autor: | V. I. Podzolkov, A. I. Tarzimanova, A. E. Bragina, I. Zh. Loria, M. V. Vetluzhskaya, А. A. Abramova, I. D. Medvedev |
|---|---|
| Jazyk: | ruština |
| Rok vydání: | 2023 |
| Předmět: | |
| Zdroj: | Кардиоваскулярная терапия и профилактика, Vol 22, Iss 6 (2023) |
| Druh dokumentu: | article |
| ISSN: | 1728-8800 2619-0125 |
| DOI: | 10.15829/1728-8800-2023-3584 |
| Popis: | Hypertension and dyslipidemia are key risk factors for cardiovascular disease. Despite the currently existing possibilities for the combined use of various classes of antihypertensive and lipid-lowering drugs, the problem of treating patients with a high risk of cardiovascular events has not lost its significance and its solution in a specific clinical situation often remains very difficult. The review analyzes current data on the efficacy and safety of the fixed-dose combination of lisinopril, amlodipine and rosuvastatin to solve the problem of a personalized approach in the treatment of comorbid patients with a high risk of cardiovascular events. |
| Databáze: | Directory of Open Access Journals |
| Externí odkaz: |
|